Stockholders' Equity |
3 Months Ended |
|---|---|
Mar. 31, 2024 | |
| Stockholders' Equity Note [Abstract] | Â |
| Stockholders' Equity |
11. Stockholders’ Equity As of March 31, 2024, there were 1,000,000,000 shares of common stock authorized, 322,622,328 shares of common stock issued, and 317,835,082 shares of common stock outstanding. As of December 31, 2023, there were 1,000,000,000 shares of common stock authorized, 318,366,628 shares of common stock issued, and 315,192,401 shares of common stock outstanding. As of March 31, 2024 and December 31, 2023, there were 5,000,000 shares of preferred stock authorized and none were issued or outstanding. We use the cost method to account for treasury stock. As of March 31, 2024 and December 31, 2023, we had 4,787,246 and 3,174,227 shares, respectively, of treasury stock. As of March 31, 2024 and December 31, 2023, the cost of treasury stock included in additional paid-in capital in the accompanying condensed consolidated balance sheets was $17,962 and $6,091, respectively. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|